October 10, 2023
JMA Executive Board Member Masaaki Miyakawa The Japan Medical Association (JMA) released a proposal on the lingering drug supply crisis on October 6, urging that authorized generics (AGs) be eliminated from the market as they might hinder healthy competition for...read more